URGN — Urogen Pharma Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareSpeculativeMid CapNeutral

Annual balance sheet for Urogen Pharma, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

	2019 December 31st	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st
Period Length:	—	—	—	—	—
Source:	10-K	10-K	10-K	10-K	10-K
Standards:	USG	USG	USG	USG	USG
Status:	Final	Final	Final	Final	Final
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	147	102	89.1	100	137
Net Total Accounts Receivable
Net Total Receivables	—	7.05	11.7	12.7	15.4
Total Inventory
Prepaid Expenses
Total Other Current Assets
Total Current Assets	149	116	114	129	169
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	4.71	4.2	3.15	3.75	2.36
Long Term Investments
Other Long Term Assets
Total Assets	202	122	120	136	178
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Total Other Current Liabilities
Total Current Liabilities	19.5	21.4	22.4	23.9	31.2
Long Term Debt
Total Long Term Debt
Total Debt
Total Other Liabilities
Total Liabilities	22.1	25.6	111	225	244
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Other Equity
Total Equity	180	96.4	8.41	-89.4	-65.2
Total Liabilities & Shareholders' Equity	202	122	120	136	178
Total Common Shares Outstanding